Jenny Hurcombe

600 total citations
9 papers, 183 citations indexed

About

Jenny Hurcombe is a scholar working on Nephrology, Molecular Biology and Surgery. According to data from OpenAlex, Jenny Hurcombe has authored 9 papers receiving a total of 183 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Jenny Hurcombe's work include Renal Diseases and Glomerulopathies (8 papers), Pancreatic function and diabetes (3 papers) and Genetic Syndromes and Imprinting (2 papers). Jenny Hurcombe is often cited by papers focused on Renal Diseases and Glomerulopathies (8 papers), Pancreatic function and diabetes (3 papers) and Genetic Syndromes and Imprinting (2 papers). Jenny Hurcombe collaborates with scholars based in United Kingdom, United States and Canada. Jenny Hurcombe's co-authors include Gavin I. Welsh, Richard J. Coward, Abigail C. Lay, Peter W. Mathieson, Lorna J. Hale, Moin A. Saleem, Beatriz Santamaría, Ángela M. Valverde, Lan Ni and Ruth Rollason and has published in prestigious journals such as Scientific Reports, Diabetologia and The Journal of Pathology.

In The Last Decade

Jenny Hurcombe

9 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jenny Hurcombe United Kingdom 7 92 56 42 29 27 9 183
Ruyi Liao China 7 106 1.2× 105 1.9× 34 0.8× 16 0.6× 28 1.0× 12 301
Yelena Drexler United States 9 72 0.8× 72 1.3× 36 0.9× 28 1.0× 13 0.5× 15 203
Meizhi Lu China 5 159 1.7× 105 1.9× 45 1.1× 15 0.5× 54 2.0× 7 315
Rodrigo Prieto Colombia 9 44 0.5× 57 1.0× 20 0.5× 45 1.6× 32 1.2× 13 215
Mengyuan Ge United States 10 131 1.4× 157 2.8× 55 1.3× 46 1.6× 23 0.9× 16 324
Gaosi Xu China 8 73 0.8× 177 3.2× 37 0.9× 26 0.9× 25 0.9× 13 297
Jessica Tituaña Spain 4 118 1.3× 144 2.6× 40 1.0× 21 0.7× 17 0.6× 5 316
Kelly Kernan United States 8 41 0.4× 111 2.0× 49 1.2× 32 1.1× 13 0.5× 10 240
Biying Meng China 9 33 0.4× 93 1.7× 41 1.0× 31 1.1× 17 0.6× 9 230

Countries citing papers authored by Jenny Hurcombe

Since Specialization
Citations

This map shows the geographic impact of Jenny Hurcombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Hurcombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Hurcombe more than expected).

Fields of papers citing papers by Jenny Hurcombe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Hurcombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Hurcombe. The network helps show where Jenny Hurcombe may publish in the future.

Co-authorship network of co-authors of Jenny Hurcombe

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Hurcombe. A scholar is included among the top collaborators of Jenny Hurcombe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Hurcombe. Jenny Hurcombe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hurcombe, Jenny, et al.. (2024). Contrasting consequences of podocyte insulin-like growth factor 1 receptor inhibition. iScience. 27(5). 109749–109749. 1 indexed citations
2.
Scott, Helen L., Keng Siang Lee, Jenny Hurcombe, et al.. (2023). AZD5438 a GSK-3a/b and CDK inhibitor is antiapoptotic modulates mitochondrial activity and protects human neurons from mitochondrial toxins. Scientific Reports. 13(1). 8334–8334. 4 indexed citations
3.
Lay, Abigail C., Lorna J. Hale, Robert J. P. Pope, et al.. (2021). IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes. Diabetologia. 64(7). 1690–1702. 25 indexed citations
4.
Hurcombe, Jenny, Abigail C. Lay, Lan Ni, et al.. (2019). Podocyte GSK3α is important for autophagy and its loss detrimental for glomerular function. FASEB BioAdvances. 1(8). 498–510. 9 indexed citations
5.
Lay, Abigail C., Jenny Hurcombe, Virginie M.S. Betin, et al.. (2017). Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor. Diabetologia. 60(11). 2299–2311. 41 indexed citations
7.
Hale, Lorna J., Jenny Hurcombe, Abigail C. Lay, et al.. (2013). Insulin directly stimulates VEGF-A production in the glomerular podocyte. American Journal of Physiology-Renal Physiology. 305(2). F182–F188. 52 indexed citations
8.
Hurcombe, Jenny, et al.. (2013). Glomerular involvement in the arthrogryposis, renal dysfunction and cholestasis syndrome. Clinical Kidney Journal. 6(2). 183–188. 6 indexed citations
9.
Hale, Lorna J., Gavin I. Welsh, Claire M. Perks, et al.. (2013). Insulin‐like growth factor‐II is produced by, signals to and is an important survival factor for the mature podocyte in man and mouse. The Journal of Pathology. 230(1). 95–106. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026